CureVac NV (CVAC)
2.56
+0.07
(+2.81%)
USD |
NASDAQ |
Nov 21, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
CureVac Price: 2.56 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 2.53 | 2.55 | 2.37 | 2.49 | 855543.0 |
Nov 19, 2024 | 2.58 | 2.65 | 2.495 | 2.50 | 677143.0 |
Nov 18, 2024 | 2.60 | 2.625 | 2.505 | 2.58 | 620058.0 |
Nov 15, 2024 | 2.66 | 2.675 | 2.50 | 2.54 | 1.103M |
Nov 14, 2024 | 2.75 | 2.79 | 2.615 | 2.67 | 667138.0 |
Nov 13, 2024 | 2.80 | 2.90 | 2.72 | 2.75 | 726546.0 |
Nov 12, 2024 | 2.95 | 2.97 | 2.75 | 2.88 | 545112.0 |
Nov 11, 2024 | 2.88 | 2.88 | 2.73 | 2.79 | 643308.0 |
Nov 08, 2024 | 2.82 | 2.94 | 2.785 | 2.84 | 716396.0 |
Nov 07, 2024 | 2.90 | 2.90 | 2.77 | 2.83 | 270112.0 |
Nov 06, 2024 | 2.86 | 2.89 | 2.70 | 2.86 | 560004.0 |
Nov 05, 2024 | 2.69 | 2.95 | 2.65 | 2.93 | 756530.0 |
Nov 04, 2024 | 2.83 | 2.88 | 2.625 | 2.71 | 880544.0 |
Nov 01, 2024 | 2.78 | 2.83 | 2.76 | 2.76 | 138567.0 |
Oct 31, 2024 | 2.81 | 2.84 | 2.71 | 2.74 | 289705.0 |
Oct 30, 2024 | 2.85 | 2.935 | 2.765 | 2.80 | 237999.0 |
Oct 29, 2024 | 2.88 | 3.03 | 2.855 | 2.89 | 707452.0 |
Oct 28, 2024 | 2.75 | 2.83 | 2.71 | 2.83 | 375534.0 |
Oct 25, 2024 | 2.72 | 2.77 | 2.71 | 2.75 | 198257.0 |
Oct 24, 2024 | 2.75 | 2.77 | 2.675 | 2.72 | 342874.0 |
Oct 23, 2024 | 2.75 | 2.78 | 2.685 | 2.70 | 244430.0 |
Oct 22, 2024 | 2.79 | 2.830 | 2.63 | 2.75 | 1.053M |
Oct 21, 2024 | 2.81 | 2.86 | 2.705 | 2.77 | 350297.0 |
Oct 18, 2024 | 2.83 | 2.86 | 2.80 | 2.80 | 165185.0 |
Oct 17, 2024 | 2.84 | 2.84 | 2.745 | 2.82 | 274012.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.31
Minimum
Apr 25 2024
136.27
Maximum
Dec 09 2020
29.36
Average
10.38
Median
Aug 29 2022
Price Benchmarks
BioNTech SE | 108.36 |
Bayer AG | 5.09 |
Affimed NV | 2.64 |
InflaRx NV | 2.10 |
Immatics NV | 7.586 |
Price Related Metrics
PE Ratio | 4.668 |
PS Ratio | 0.9633 |
Price to Book Value | 0.7095 |
Price to Free Cash Flow | 5.390 |
Earnings Yield | 21.42% |
Market Cap | 574.31M |
Operating PE Ratio | 3.902 |
Normalized PE Ratio | 4.810 |